Skip to main content
. 2021 Nov 19;11:22624. doi: 10.1038/s41598-021-02050-3

Figure 1.

Figure 1

Clinical serum 5-HT levels determined by serotonin ELISA assay (Eagle Biosciences, Amherst, NH) in CD patients with or without MAP infection vs healthy control Subjects (N = 40 per each group). Values were pre-tested for normal distribution using the Kolmogorov–Smirnov normality test. Significance among experiments was assessed by two-way analysis of variance (ANOVA) followed by Bonferroni correction test. *P value < 0.05 compared to healthy controls. #P value < 0.05 compared to healthy controls or CD MAP negative patients.